annelise bennaceur griscelli

PROFESSEUR HEMATOLOGIE

Université Paris Diderot UFR de Médecine - Saint-Louis Hospital - APHP

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professeur Annelise Bennaceur Griscelli is a faculty member at Université Paris-Saclay Faculté de Médecine, APHP, in France. Her research encompasses hematology with a focus on induced pluripotent stem cells (iPSCs), therapeutic angiogenesis, and natural killer cell functionality. Recent publications include works on iPSC haplobanks, endothelial colony-forming cells, and innovative therapies for hematological malignancies.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (1)

frank griscelli

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

annelise bennaceur griscelli

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Correction: Current Landscape of iPSC Haplobanks.

Direct Reprogramming of Hepatocytes Into JAK/Stat-Dependent LGR5+ Liver Cells Able to Initiate Intrahepatic Cholangiocarcinoma

Comparative Evaluation of Endothelial Colony-Forming Cells from Cord and Adult Blood vs. Human Embryonic Stem Cell-Derived Endothelial Cells: Insights into Therapeutic Angiogenesis Potential.

Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities.

Current Landscape of iPSC Haplobanks.

Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA.

BIRC-3 mutated monoclonal B lymphocytosis without evolution to chronic lymphocytic leukemia (CLL).

Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model.

Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs)

Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).

Collaborators (1)

frank griscelli

Make your next move.